Panel Discussion: Choosing the Right Diagnostic Partner for the Right Study to Deliver Regulatory-Grade Liquid Biopsy Data

• Matching assay type, sensitivity and turnaround to the study question, from patient selection and enrichment to response monitoring and MRD
• Evaluating vendors on analytical validation, quality systems and regulatory track record, so data stands up to agency scrutiny
• Structuring the sponsor and vendor relationship early, from contracting and sample logistics to bridging plans if the assay changes mid-program

Speakers:

Stephen huang

Executive Director, Clinical Biomarkers & CDx

Avenzo Therapeutics

Fernando Cruz-Guilloty

Director & Lead - Oncology & Precision Medicine & Diagnostics

Johnson & Johnson